Skip to main content
. 2021 May 21;17(3):294–305. doi: 10.2174/1573403X16999200817111150

Fig. (3).

Fig. (3)

Net clinical benefit of rivaroxaban + aspirin vs aspirin in patients with stable coronary artery disease according to age and the history of myocardial infarction. Data from the COMPASS study [34]. (A higher resolution / colour version of this figure is available in the electronic copy of the article).